Programme for CCHFV Africa 2023

2-4 May 2023Cape Town, South Africa

Confirmed Keynote speakers

Prof Ali Mirazimi
Prof Lucille Blumberg
Prof Dennis Bente
Dr Jacqueline Weyer
Prof Felicity Burt
Dr David Hawman
Prof Nazif Elaldi

2 May 2023

 

During the day: Flights arriving in Cape Town

 19:00-21:00 Welcoming and registration at Two Oceans Aquarium




3 May 2023

Time Session 1 Presenter Country: Duration Session chairs
08:00 - 08:30 Registration, poster setup and coffee
08:30 - 08:45 Welcoming remarks Felicity Burt and Ali Mirazimi 15 min
08:45 - 09:30 Keynote I - Modern approaches to study CCHF virus replication Ali Mirazimi Sweden 45 min F Burt
Session 2 Session duration: 90 min __________________
09:30 - 10:00 Keynote II - Clinical aspects of CCHF Lucille Blumberg South Africa 30 min J Weyer
10:00 - 10:15 Emergence of Crimean-Congo haemorrhagic fever in Uganda: Evidence from a country-wide seroepidemiological study in cattle Luke Nyakarahuka Uganda 15 min
10:15 - 10:30 Infestation rates, genetic diversity, of ixodid ticks and detection of Crimean-Congo hemorrhagic fever virus in Hyalomma spp. collected at livestock markets in Yaoundé, Cameroon Basile Kamgang Cameroon 15 min
10:30 - 10:45 Sero-epidemiology of Crimean-Congo haemorrhagic fever virus in non-human primates in Kenya Vincent Obanda Kenya 15 min
10:45 - 11:00 ERINHA's contribution to research into CCHFV and other high-consequence pathogens: opportunities for African researchers Jonathan Ewbank France 15 min
11:00 - 11:15 Mid-morning break Poster viewing 15 min
Session 3 Session duration: 90 min __________________
11:15 - 11:45 Keynote III - Crimean-Congo hemorrhagic fever risk assessment in countries: five ways to improve the design and the analysis of our One Health surveillance efforts Dennis Bente USA 30 min D Hawman
11:45 - 12:00 Adoption of the One Health approach to study Crimean-Congo hemorrhagic fever among rural communities in Burkina Faso: A study protocol Abdoul Kader Ilboudo Burkina Faso 15 min
12:00 - 12:15 CCHFV in the Central African Republic: Based on current data, what strategies addressed today to respond to any possible emergence/re-emergence Carine Ngoagouni Central Africa Republic 15 min
12:15 - 12:30 Risk mapping of Crimean Congo hemorrhagic fever Stephen Owambo Oloo Kenya 15 min
12:30 - 12:45 Crimean-Congo hemorrhagic fever in Uganda, 2013-2019: Clinical, laboratory and epidemiological features of hospitalized patients Stephen Balinandi Uganda 15 min
12:45 - 13:45 Lunch 60 min
Session 4 Session duration: 90 min _________________
13:45 - 14:15 Keynote IV - Laboratory diagnosis of CCHF Jacqueline Weyer South Africa 30 min F Burt
14:15 - 14:30 Crimean-Congo haemorrhagic fever virus epidemiology in Tunisia: One Health concept Elyes Zhioua Tunisia 15 min
14:30 - 14:45 The risk of Crimean-Congo hemorrhagic fever in western Kenya: Investigating presence in ticks and livestock at livestock markets and slaughterhouses Tatenda Chiuya Kenya 15 min
14:45 - 15:00 Serological evidence of Crimean-Congo haemorrhagic fever and Brucella spp. in febrile patients in Mozambique Inocêncio Chongo Mozambique 15 min
15:00 - 15:15 Another Crimean-Congo hemorrhagic fever outbreak in the cattle corridor of Uganda, July 2022: Time to think about a national tick control program? Jane Frances Zalwango Uganda 15 min
15:15 - 15:30 Mid-afternoon break 15 min
Session 5 Session duration: 90 min ________________
15:30 - 15:45 The detection of Crimean-Congo haemorrhagic fever virus in ticks, and seroprevalence in cattle, veterinarians, and wildlife, farm and abattoir workers in South Africa. Veerle Msimang South Africa 15 min N Makoah
15:45 - 16:00 Modelling spatiotemporal transmission patterns of Crimean Congo haemorrhagic fever virus for targeted surveillance and control of the disease in Kenya Bernard Bett Kenya 15 min
16:00 - 16:15 First serological evidence of Crimean-Congo haemorrhagic fever in febrile patients in Mozambique Argentina Felisbela Muianga Mozambique 15 min
16:15 - 16:30 Crimean-Congo Hemorrhagic Fever Outbreak — Central Uganda, August–September 2017 Susan Kizito Kironde Uganda 15 min
16:30 - 16:45 Crimean-Congo haemorrhagic fever virus exposure in livestock and humans in Northern Tanzania Tito Kibona Tanzania 15 min
16:45 - 17:00 Investigation of geographical distribution of Crimean-Congo hemorrhagic fever in Sivas Province, Turkey İlhan Çetin Turkey 15 min
19:00 - 21:00 Dinner





4 May 2023

 

Time Session 6 Presenter Country Duration Session chairs
08:00 - 08:30 Welcoming coffee
08:30 - 08:45 Welcoming remarks Nigel Makoah South Africa ___________________
08:45 - 09:30 Keynote V - Epidemiology of CCHF Felicity Burt South Africa 45 min A Mirazimi
Session 7 Session duration: 90 min
09:30 - 10:00 Keynote VI - Adaptive immunity controls and contributes to disease in CCHFV infected wild-type mice David Hawman USA 30 min A Mirazimi
10:00 - 10:15 Crimean-Congo haemorrhagic fever; Seroprevalence in humans, livestock and wildlife in Isiolo, Northern Kenya Eugine Mukhaye Kenya 15 min
10:15 - 10:30 Sporadic Crimean-Congo haemorrhagic fever outbreaks associated with tick exposures: Western and Central Uganda, 2018 - 2019 Bernadette Basuta Mirembe Uganda 15 min
10:30 - 10:45 Molecular and serological evidence of Crimean-Congo hemorrhagic fever virus prevalence in livestock and ticks in Cameroon Francine Yousseu Sado Cameroon 15 min
10:45 - 11:00 Surveillance activities on Congo-Crimea fever in Benin Anges Yadouleton Benin 15 min
11:00 - 11:15 Mid-morning break 15 min
Session 8 Session duration: 90 min ___________________
11:15 - 11:45 Keynote VII - Clinical aspects of CCHF: A 20-year experience from Turkey Nazif Elaldi Turkey 30 min D Bente
11:45 - 12:00 One Health overview of Crimean-Congo haemorrhagic fever virus epidemiology in North Africa Wasfi Fares Tunisia 15 min
12:00 - 12:15 Plant-produced Crimean-Congo haemorrhagic fever virus nucleoprotein for use in indirect ELISA Ed Rybicki South Africa 15 min
12:15 - 12:30 Serological and molecular study of Crimean-Congo hemorrhagic fever virus in cattle from selected districts in Uganda Lawrence Mugisha Uganda 15 min
12:30 - 12:45 Transmission dynamics of Crimean Congo Haemorrhagic fever virus (CCHFV); Evidence of circulation in humans, livestock, and rodents selected semi-arid ecologies, Kenya Rosemary Sang Kenya 15 min
12:45 - 13:45 Lunch 60 min
Session 9 Session duration: 60 min ___________________
13:45 - 14:00 First detection of antibodies specific to Crimean-Congo haemorrhagic fever virus in rural populations of Gabon Linda Bohou Kombila Gabon 15 min J Weyer
14:00 - 14:15 Tick-animal virus-transmission blocking vaccines: friend or foe toward One Health control of Crimean-Congo hemorrhagic fever human infection? Charles Ndawula Uganda 15 min
14:15 - 14:30 Toward multidisciplinary One Health approach for effective Crimean-Congo surveillance in Senegal Oumar Faye Senegal 15 min
14:30 - 14:45 Seroepidemiology of Crimean-Congo hemorrhagic fever virus infection among pastoral communities in Caia and Buzi districts, Mozambique, 2018 John Oludele Mozambique 15 min
14:45 - 15:00 Mid-afternoon break 15 min
Session 10 Session duration: 60 min ____________________
15:00 - 15:15 Crimee-Congo haemorragic fever (CCHF), evidence of VecBoVirus existence in Central African Republic (CAR), antibody prevalence and isolation in ticks, Zebu cattle, dogs and humans, review Ulrich Vickos Central African Republic 15 min N Makoah
15:15 - 15:30 Study of the circulation of Crimean-Congo hemorrhagic fever (CCHF) and tick-borne encephalitis (TBE) viruses in shepherds and febrile patients in Cameroon Paul Moundipa Fewou Cameroon 15 min
15:30 - 15:45 Risk factors for Crimean-Congo haemorrhagic fever (CCHF) virus exposure in farming communities in Uganda Stella Atim Uganda 15 min
15:45 - 16:00 A One Health Approach to understanding the Ecology of Crimean Congo Haemorrhagic Fever Virus (CCHFV) in Tanzania Elichilia Shao Tanzania 15 min
16:00 - 17:00 Way forward CCHF Africa panel discussion Felicity Burt, Ali Mirazimi and Jacqueline Weyer 60 min
17:00 Closure and thanks Felicity Burt and Ali Mirazimi

We use cookies to make interactions with our websites and services easy and meaningful, to better understand how they are used and to tailor advertising. You can read more and make your cookie choices here. By continuing to use this site you are giving us your consent to do this.

Accept